Dr. Ming-Wei Wang (Director, the National Center for Drug Screening/Chinese National Compound Library and Dean, School of Pharmacy, Fudan University) attended the last Board Meeting of Novo Nordisk-Union Diabetes Research Talent Fund (UTF) in Beijing in the morning of April 22, 2017. The meeting began with an overview of the fund’s operational history since its inception in 2010, followed by final project reports presented by five senior physicians and scientists from Fuwai Hospital, Peking Union Medical College Hospital, Institute of Basic Medical Sciences and Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences/Peking Union Medical College (CAMS/PUMC). The participants highly commended the significant achievements made during the past six years. Chinese Board members who attended the meeting also include Drs. Jianwei Wang (Director, Department of Science and Technology, CAMS/PUMC), Yunbin Zhu (Executive Deputy Director, Presidents’ Office, CAMS/PUMC) and Hua Zhang (Deputy Director, Department of Science and Technology, CAMS/PUMC). Representing Novo Nordisk, Drs. Boerge Diderichsen (Vice President), Baoping Wang (President, Novo Nordisk China R&D Center), Fang Zhang (Vice President, Novo Nordisk China R&D Center) and Yu Tong (Senior Medical Affairs Director, Novo Nordisk Region China). Professor Zhiyong Liang and Professor Zhongjie Fan, both from Peking Union Medical College Hospital, as well as Madam Caiyun Zheng, Project Manager at Department of Science and Technology, CAMS/PUMC were present.